$8,000
Est. net congressional buying / selling (2 years). Updated Jul 8, 2026

Similar companies

CompanyEst. Net Value
Healthequity
Healthequity
HQY
$16,000
McKesson
McKesson
MCK
$89,000

Are Members of Congress Buying or Selling Veeva Systems?

No members of Congress have reported trading Veeva Systems (VEEV) stock in the past 90 days. The history below covers the past two years.

Congressional trading is one of the alternative data signals AltIndex tracks as part of the VEEV AI Score. For corporate insider activity, see VEEV insider transactions. To browse trades across every ticker, visit the Congress Trading tracker.

Which Congress Members Are Trading Veeva Systems?

Member of CongressActivityTradesLast Trade
Rob Bresnahan Mixed $16,000 2 May 29, 2025
Ro Khanna Bought $8,000 1 Jun 2, 2026

VEEV Congressional Trade History

Member of CongressTrade DateTypeEstimated Size
Ro Khanna Jun 2, 2026 Buy $1K – $15K
Rob Bresnahan May 29, 2025 Buy $1K – $15K
Rob Bresnahan May 16, 2025 Sell $1K – $15K

Frequently Asked Questions: Veeva Systems Congress Trading

No members of Congress have reported buying or selling VEEV stock in the past 90 days. Congressional trades are disclosed under the STOCK Act — view the full history on this page.

Some research has found that congressional stock trades have at times outperformed the market, possibly due to informational advantages. AltIndex tracks these trades as one of 25+ signals in the AI Score. See the full Congress Trading tracker for all recent trades.

Ro Khanna bought Veeva Systems (VEEV) stock most recently, on June 2, 2026.

The estimated net value of congressional trades in Veeva Systems over the past 2 years is positive, at $8,000, meaning members of Congress have on balance bought more than they have sold.

Members of Congress can have early visibility into legislation, regulation, and government contracts that may affect a company. Tracking their disclosed trades — alongside other signals — can offer additional context for investment decisions.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.